Stay updated on Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.

Latest updates to the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page
- Check6 days agoChange DetectedRelated-topic references to “Atopic dermatitis” and “MedlinePlus Genetics” are removed from the page.SummaryDifference0.1%

- Check13 days agoChange DetectedThe study record for the completed ECZTRA 7 trial is displayed, including its design, eligibility criteria, locations, interventions, and outcome measures. Study history and supporting documents are also available.SummaryDifference74%

- Check20 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision advances from v3.7.1 to v3.7.2 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.